Cita APA

Catalán Santos, Ú., López de las Hazas Mingo, M. d. C., Piñol Felis, C., Rubió Piqué, L., Motilva Casado, M. J., Fernández Castillejo, S., & Solà, R. (2018). Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway.

Citación estilo Chicago

Catalán Santos, Úrsula, María del Carmen López de las Hazas Mingo, Carme Piñol Felis, Laura Rubió Piqué, Mª José Motilva Casado, Sara Fernández Castillejo, y Rosa Solà. Hydroxytyrosol and Its Main Plasma Circulating Metabolites Attenuate the Initial Steps of Atherosclerosis Through Inhibition of the MAPK Pathway. 2018.

Cita MLA

Catalán Santos, Úrsula, et al. Hydroxytyrosol and Its Main Plasma Circulating Metabolites Attenuate the Initial Steps of Atherosclerosis Through Inhibition of the MAPK Pathway. 2018.